Page last updated: 2024-08-23

4-methoxyamphetamine and Lymphoma, Non-Hodgkin

4-methoxyamphetamine has been researched along with Lymphoma, Non-Hodgkin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19904 (80.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
TAYLOR, L1
BUTENKO, ZA; DAL', MK1
MAHER, JA1
GAULD, WR1
Amemiya, Y; Hasegawa, J; Noguchi, I; Seto, K1

Other Studies

5 other study(ies) available for 4-methoxyamphetamine and Lymphoma, Non-Hodgkin

ArticleYear
Death following brief steroid withdrawal before palliative surgery in a case of reticulum cell sarcoma.
    American practitioner and digest of treatment, 1956, Volume: 7, Issue:6

    Topics: Death; Fever; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasms; Palliative Care; Sarcoma; Steroids

1956
[Possibility of transplantation of lymphoblastoma in various periods following death of experimental animals].
    Biulleten' eksperimental'noi biologii i meditsiny, 1957, Volume: 43, Issue:6

    Topics: Animals; Animals, Laboratory; Death; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasms, Experimental

1957
A statistical study of lymphoblastoma in the necropsy series at the University of Michigan Hospital. II. Incidence of complications, and cause of death.
    Medical bulletin (Ann Arbor, Mich.), 1958, Volume: 24, Issue:1

    Topics: Autopsy; Cause of Death; Death; Humans; Incidence; Lymphoma; Lymphoma, Non-Hodgkin

1958
Lymphosarcoma terminating with leukaemia.
    Edinburgh medical journal, 1951, Volume: 58, Issue:10

    Topics: Death; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin

1951
Postoperative death of a patient in apparent remission of malignant lymphoma after dissection for squamous cell carcinoma.
    Oral surgery, oral medicine, and oral pathology, 1992, Volume: 74, Issue:1

    Topics: Aged; Carcinoma, Squamous Cell; Cyclophosphamide; Death; Disseminated Intravascular Coagulation; Humans; Immunocompromised Host; Immunosuppression Therapy; Lymphoma, Non-Hodgkin; Male; Mandibular Neoplasms; Multiple Organ Failure; Neoplasms, Second Primary; Postoperative Complications; Recurrence; Remission Induction

1992